Contineum Therapeutics (CTNM) Return on Equity (2024)
Historic Return on Equity for Contineum Therapeutics (CTNM) over the last 2 years, with Q3 2025 value amounting to 0.08%.
- Contineum Therapeutics' Return on Equity rose 800.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.65% for FY2024, which is N/A changed from last year.
- Contineum Therapeutics' Return on Equity amounted to 0.08% in Q3 2025, which was up 800.0% from 0.14% recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Return on Equity ranged from a high of 0.08% in Q3 2025 and a low of 0.44% during Q2 2024